Relatório global de análise do tamanho, quota e tendências do mercado de alopécia androgenética – Visão geral do setor e previsão para 2031

Análise de mercado da alopécia androgenética

O mercado global de alopécia androgenética está a registar um crescimento substancial, impulsionado pela crescente consciencialização sobre os tratamentos para a queda de cabelo e por uma prevalência crescente de alopécia androgenética em mulheres e homens. Os avanços nas opções terapêuticas, incluindo a utilização de minoxidil e finasterida, juntamente com tratamentos inovadores, como a terapia laser de baixa intensidade e o transplante capilar, estão a expandir o panorama do mercado. Além disso, a mudança para a medicina personalizada está a promover o desenvolvimento de tratamentos personalizados com base nos perfis individuais dos pacientes. O aumento do investimento em investigação e desenvolvimento, como evidenciado por vários ensaios clínicos , está também a impulsionar a expansão do mercado. Além disso, espera-se que a tendência crescente para procurar soluções eficazes para a queda de cabelo em ambientes de cuidados domiciliários, alimentada pelo aumento dos rendimentos disponíveis e pelos avanços tecnológicos, melhore a acessibilidade a estes tratamentos. Como resultado, o mercado da alopécia androgenética está preparado para um crescimento significativo, oferecendo inúmeras oportunidades tanto para os players estabelecidos como para os novos participantes na indústria capitalizarem esta base de consumidores em expansão que procuram soluções eficazes de restauração capilar.

Tamanho do mercado de alopécia androgenética

O tamanho do mercado global de alopécia androgenética foi avaliado em 1,43 mil milhões de dólares em 2023 e deverá atingir 2,98 mil milhões de dólares até 2031, com um CAGR de 9,60% durante o período de previsão de 2024 a 2031. Além dos insights sobre os cenários de mercado, como o valor de mercado, a taxa de crescimento, a segmentação, a cobertura geográfica e os grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também a análise especializada aprofundada, a epidemiologia dos doentes, a análise de pipeline, a análise de preços e a estrutura regulatória.

Tendências do mercado da alopécia androgenética

“ Aumento da adoção de abordagens de tratamento personalizadas”

O mercado da alopécia androgenética está a testemunhar uma tendência notável para a crescente adoção de abordagens de tratamento personalizadas que atendem às necessidades individuais dos doentes. À medida que aumenta a consciência sobre a doença, os doentes procuram terapias personalizadas que se alinhem com os seus perfis genéticos específicos e preferências de tratamento. Por exemplo, os avanços na farmacogenómica estão a permitir aos prestadores de cuidados de saúde oferecer soluções personalizadas com base em testes genéticos, que podem determinar o regime de tratamento mais eficaz para a queda de cabelo. Além disso, a ascensão da telemedicina está a facilitar consultas que permitem aos pacientes receber recomendações personalizadas sem a necessidade de visitas presenciais. Empresas como a Hairmax estão a aproveitar estas tendências, fornecendo dispositivos de terapia laser personalizados que podem ser utilizados convenientemente em casa. Esta mudança para soluções personalizadas aumenta a satisfação e a adesão dos doentes e impulsiona o crescimento do mercado, atraindo uma base de consumidores mais ampla que valoriza os cuidados individualizados no tratamento da alopécia androgenética.

Âmbito do relatório e segmentação do mercado de alopécia androgenética       

Androgenetic Alopecia Market Definition

Androgenetic alopecia, commonly known as male or female pattern baldness, is a hereditary condition characterized by progressive hair thinning and loss. It results from a combination of genetic predisposition and hormonal influences, particularly the effects of androgens (male hormones) on hair follicles. In men, this condition typically manifests as a receding hairline and balding at the crown, while women generally experience diffuse thinning across the scalp, often retaining their frontal hairline. The condition can begin as early as puberty and may lead to significant psychological distress due to its impact on self-image.

Androgenetic Alopecia Market Dynamics

Drivers

• Increasing Prevalence of Hair Loss

The increasing prevalence of hair loss, particularly androgenetic alopecia, is a significant market driver, with studies indicating that approximately fifty percent of men and a substantial number of women experience some degree of hair thinning by the age of 50. Factors contributing to this rise include genetic predisposition, hormonal fluctuations, and lifestyle elements such as stress and poor nutrition. For instance, research has shown that androgens, particularly dihydrotestosterone (DHT), play a crucial role in hair follicle miniaturization, leading to progressive hair loss. Additionally, a report from the American Academy of Dermatology noted that androgenetic alopecia affects around 25% of men in their twenties and nearly 75% by age of 70. This growing incidence is creating a larger consumer base actively seeking effective treatment options, which drives demand for various therapies, including topical solutions such as minoxidil and surgical interventions such as hair transplants. As more individuals seek solutions to combat hair loss, the market for androgenetic alopecia treatments is expected to expand significantly.

• Increasing Aging Population

The aging population significantly drives the demand for effective treatments for androgenetic alopecia, as the incidence of hair loss increases with age. According to the World Health Organization, by 2050, the number of individuals aged 60 and older is expected to reach 2 billion, representing approximately 21% of the global population. Research indicates that nearly 75% of men and about 50% of women will experience some degree of hair thinning by the age of 70. This demographic shift creates a larger consumer base actively seeking hair loss treatments to maintain their appearance and self-esteem. As older adults become more aware of available therapeutic options ranging from pharmaceutical treatments such as minoxidil and finasteride to surgical interventions such as hair transplants the market for androgenetic alopecia solutions is anticipated to expand, catering to the growing demand for effective and accessible treatments tailored to this demographic.

Opportunities

• Increasing Technological Advancements in Treatment Solutions

Technological advancements in treatment solutions for androgenetic alopecia represent a significant market opportunity, enhancing both the effectiveness and accessibility of therapies. Innovations such as new pharmacological solutions, including FDA-approved medications such as finasteride and minoxidil, have improved patient outcomes by promoting hair regrowth and slowing hair loss. Moreover, advanced laser therapy devices, such as low-level laser therapy (LLLT) systems, have gained popularity due to their non-invasive nature and proven efficacy in stimulating hair follicles. For instance, devices such as the iRestore Laser Hair Growth System are gaining traction among consumers for their ease of use at home. Additionally, minimally invasive hair transplant techniques, such as the Follicular Unit Extraction (FUE) method, have revolutionized surgical options, allowing for more precise and natural-looking results with reduced recovery time. These advancements meet the increasing demand for effective hair restoration solutions and cater to a broader audience, including those who may have previously considered traditional methods too invasive or costly. As technology continues to evolve, it opens new avenues for growth and innovation within the androgenetic alopecia market.

• Growing Awareness and Acceptance of Hair Loss Conditions

Growing awareness and acceptance of hair loss conditions and their treatment solutions present a significant market opportunity for the androgenetic alopecia sector. Recent studies indicate that over 60% of individuals experiencing hair loss actively seek information about treatment options, reflecting a notable shift in societal attitudes towards hair restoration therapies. This change is facilitated by increased visibility in mainstream media, where celebrities and influencers openly discuss their hair loss journeys and the various treatments they have pursued. For instance, platforms such as Instagram and TikTok feature hashtags such as #HairRestoration, which attract millions of views and foster communities that encourage seeking solutions for hair loss. Additionally, educational campaigns by dermatologists and hair restoration clinics have played a crucial role in informing the public about effective treatments, such as topical solutions such as minoxidil and surgical options such as hair transplants. As more individuals recognize the benefits of addressing hair loss, the demand for effective androgenetic alopecia cure continues to rise, creating a robust market opportunity for companies specializing in androgenetic alopecia solutions.

Restraints/Challenges

• Affordability and Cost Barriers

Affordability and cost barriers present significant challenges to the global androgenetic alopecia market, limiting access to effective treatments for many individuals, particularly in low-income regions. Advanced solutions such as hair transplants can cost several thousand dollars, making them prohibitive for a large segment of the population. For instance, the average cost of a hair transplant in the U.S. ranges several thousand dollars, depending on the procedure's complexity and the number of grafts required. This financial burden can deter patients from seeking necessary treatment and may also discourage healthcare providers from investing in the latest technologies and solutions. Additionally, prescription medications such as finasteride and minoxidil, while effective, can also impose ongoing costs that not everyone can afford, particularly when health insurance plans do not cover these treatments. Consequently, the high costs associated with androgenetic alopecia treatments restrict patient access, creating a barrier to market growth and limiting the potential for broader adoption of innovative solutions in addressing hair loss.

• Complex Regulatory Frameworks

Regulatory hurdles pose significant challenges for the global androgenetic alopecia market, as stringent requirements and lengthy approval processes can delay the introduction of innovative therapies. Companies developing new treatments must navigate complex regulatory frameworks set by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), which require extensive clinical trials to demonstrate safety and efficacy. For instance, the approval process for a new hair restoration drug can take several years, during which companies must invest substantial resources into research, development, and compliance with regulatory standards. This can be particularly daunting for smaller companies or start-ups that lack the financial backing to endure prolonged timelines without generating revenue. Consequently, delays in obtaining necessary approvals can hinder market entry for potentially ground-breaking therapies, limiting patient access to the latest solutions for androgenetic alopecia. The combination of regulatory scrutiny and the need for comprehensive clinical data can slow down innovation, ultimately affecting the availability of effective treatments for those suffering from hair loss.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Androgenetic Alopecia Market Scope

The market is segmented on the basis of treatment, gender, route of administration, end users, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Minoxidil
• Finasteride
• Dutasteride
• Oral Antiandrogens
• Hair Transplant
• Low-Level Laser Therapy
• Counseling
• Others

Gender

• Male
• Female

Route of Administration

• Oral
• Topical

End-Users

• Clinics
• Hospitals
• Diagnostic Centers
• Surgical Centers
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Androgenetic Alopecia Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, treatment, gender, route of administration, end users, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the androgenetic alopecia market, driven by the presence of significant industry players and a growing prevalence of hair loss among the population. The region's high disposable income allows consumers to invest in advanced treatments, which often come at a premium price. Additionally, the development of innovative therapeutic solutions is fostered by a robust healthcare infrastructure that supports research and development. As a result, North America continues to be a hub for the latest advancements in hair loss treatments, further solidifying its dominant market position.

Asia-Pacific is projected to experience substantial growth in the Androgenetic Alopecia market from 2024 to 2031. This expansion is primarily driven by a rising incidence of respiratory disorders, including chronic respiratory diseases and other dysfunctions, which heightens demand for effective respiratory care solutions. Additionally, ongoing improvements in healthcare infrastructure, particularly in emerging economies within the region, facilitate greater access to advanced medical technologies. These factors, combined with increased healthcare investments, position Asia-Pacific as a key growth area in the forecast period.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Androgenetic Alopecia Market Share

O cenário competitivo do mercado fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Os líderes de mercado da Alopecia androgenética que operam no mercado são:

• Vitabiotics Ltd. (Reino Unido)
• Sun Pharmaceutical Industries Ltd. (Índia)
• Merck & Co., Inc.
• (Índia)
• Cipla (Índia)
• (EUA)
• Laboratório Native (França)
• Aurobindo Pharma (Índia)
• Hairmax International, LLC (EUA)
• Sistema de crescimento capilar iRESTORE (EUA)
• Curallux, LLC (EUA)
• Apira Science (EUA)
• (EUA)
• Lifes2good (EUA)

Últimos Desenvolvimentos no Mercado da Alopecia Androgenética

• Em dezembro de 2023, a Sun Pharmaceutical Industries Ltd. formou uma parceria estratégica com a Aclaris, concedendo à Sun Pharma direitos exclusivos para utilizar deuruxolitinib, um inibidor de JAK, e outras variações isotópicas de ruxolitinib para o tratamento da alopécia areata e da alopécia androgenética
• Em julho de 2023, a Cosmo Pharmaceuticals lançou ensaios clínicos de fase 3 para o seu medicamento tópico bloqueador dos recetores de androgénios, Clascoterone Solution
• Em junho de 2023, a Dr. Reddy's Laboratories Ltd. anunciou a expansão da sua divisão de genéricos na Índia com a introdução do RgenX, um segmento dedicado que oferece uma gama mais ampla de produtos acessíveis para os doentes
• Em junho de 2023, a Pfizer, Inc. recebeu a aprovação da FDA dos EUA para o Litfulo (ritlecitinib), um tratamento para a queda de cabelo relacionada com alopécia, que atua bloqueando os sinais inflamatórios que contribuem para o aumento da queda de cabelo
• Em março de 2023, a Sun Pharmaceutical Industries Ltd. finalizou a aquisição da Concert Pharmaceuticals, Inc., uma empresa focada no desenvolvimento de opções de tratamento inovadoras para diversas formas de alopécia

SKU-63691